grandeo logo
grandeo logo

Immunocore

Immunocore logo

Financial bias: 2.3
Team bias: 3.5
trending

Immunocore

Summary:
Healthcare

#grandeo100 #healthcare


Immunotherapeutic drugs based on proprietary T-cell receptor (TCR) technology
Venture:
IMMUNOCORE LIMITED
active
#06456207

Born: Dec07

GOticker:
immunocore
API:
If you would like to use the API then please register / logon



valuation



market price valuation
GBP 460m

media driven valuation
GBP 460m

valuations methodology

algo says

Significant experience in the industry

Team have worked together before

Investment injected since last published accounts

Profitable




featured

finances

as at ebit na(nl) equity debt cash
31Dec16 -54,433 175,224 227,038 19,996 176,590
Source: UK Companies House - Audited Accounts KPMG GBP 'OOOs
31Dec15 17,169 214,253 223,331 30,461 219,730
Source: Companies House KPMG GBP 'OOOs
30Sep14 -7,313 -2,105 25,609 44,392 50,851
Source: Companies House KPMG GBP 'OOOs
30Sep13 -4,793 3,003 26,195 8,143 16,323
Source: Companies House KPMG GBP 'OOOs
If you would like to view more information then please register / logon

controllers

shareholders

If you would like to view the shareholders (people and companies) then please register / logon

cap-table

EQUITY GBP ORDINARY

THE SHARES HAVE ATTACHED TO THEM FULL VOTING, DIVIDEND AND CAPITAL DISTRIBUTION (INCLUDING ON WINDING UP) RIGHTS; THEY DO NOT CONFER ANY RIGHTS OF REDEMPTION.

18Dec16

EQUITY GBP SERIES A

THE SHARES HAVE ATTACHED TO THEM FULL VOTING AND CAPITAL DISTRIBUTION (INCLUDING ON WINDING UP) RIGHTS; THEY DO NOT CONFER ANY RIGHTS OF REDEMPTION. AN 8% FIXED NON-CUMULATIVE PREFERENCE DIVIDEND IS PAYABLE ON THE SHARES.

18Dec16

EQUITY GBP G1 SHARES

No explanation for G1 Shares rights.

18Dec17

people (10)

JAKOBSEN, Bent Karsten, Dr logo 1 2
JAKOBSEN, Bent Karsten, Dr
#director #founder #cso
06Oct08
@adaptimmune @avidex

#Danish #59yo
CROSS, Nicholas John logo 2 24
CROSS, Nicholas John
#director #founder
06Oct08
@avidex @adaptimmune

#British #71yo
KNOWLES, Jonathan Kenneth Charles, Dr logo 1 3
KNOWLES, Jonathan Kenneth Charles, Dr
#director #chairman
01Jan10
@roche

#British #70yo
BELL, John Irving, Sir logo 2 2
BELL, John Irving, Sir
#director
12Mar15
@oxon @avidex

#British/Canadian #66yo
LAING, Ian Michael logo 14 44
LAING, Ian Michael
#director #founder
06Oct08
@adaptimmune

#British #71yo
HOTCHKISS, Andrew logo 1 1
HOTCHKISS, Andrew
#director
06Feb18

#British #55yo
HUSSAIN, Shah Abbas logo 1 1
HUSSAIN, Shah Abbas
#director
12May17
@gsk

#British #53yo
HOWD, Adrian Graham logo 6 9
HOWD, Adrian Graham
#director
16Jul15
@malin @berenberg

#British #46yo
ROBINSON, George Edward Silvanus logo 6 11
ROBINSON, George Edward Silvanus
#director
02Dec08
@sloanerobinson @oxon

#British #61yo
OAKWOOD CORPORATE SECRETARY LIMITED logo 1 1
OAKWOOD CORPORATE SECRETARY LIMITED
#corporate-secretary
01Mar16
FORSTER, Eliot Richard, Dr
#director #ceo
05Jan15
06Feb18 (res)

HENRY, Margaret
#secretary
21Jul14
04Feb15 (res)

BADDELEY, Patrick Charles Morrish
#director
18Dec07
15Sep08 (res)

CHRIST, Arnd
#director
25May10
18Sep12 (res)

COULTER, Eva-Lotta
#director
07May13
16Jul15 (res)

HEINRICH, Peter, Dr
#director
06Oct08
26May09 (res)

KLAUE, Thomas, Dr
#director
26May09
22Apr10 (res)

LLEWELLYN-DAVIES, Peter
#director
01Oct12
08Jul14 (res)

NOBLE, James Julian
#director
15Sep08
16Jul15 (res)

MARTIN, George Kelly
#director
16Jul15
20Sep17 (res)
@Malin @MeryllLynch
ALDWYCH SECRETARIES LIMITED
#corporate-secretary
04Feb15
01Mar16 (res)

ALDWYCH SECRETARIES LIMITED
#corporate-secretary
18Dec07
21Jul14 (res)

news

Bill Gates says investing in cancer therapies could 'control all infectious disease'
Business Insider 09Jan18
British Unicorn Gets $40M Boost from Bill & Melinda Gates Foundation
Labiotech.eu 18Sep17
Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting
Immunocore 06Jun16
US 'orphan status' for Immunocore's eye cancer drug
PharmaTimes 25Jan16
Immunocore in record European biotech raising
Financial Times 16Jul15
9/22/2018 10:48:01 AM

grandeo limited | 1 fore street london uk | grandeo.co | +44 203 900 0340 | info@grandeo.co | 2017-2018 search